Advertisement

Reactions Weekly

, Volume 1694, Issue 1, pp 341–341 | Cite as

Ombitasvir/paritaprevir/ritonavir

Hepatotoxicity: case report
Case report
  • 14 Downloads

Reference

  1. Janczewska E, et al. Efcacy of ombitasvir/paritaprevir/ritonavir +/- dasabuvir +/- ribavirin in patients with HCV genotype 1 and 4 infection-fnal data from the real-world AMBer study. Clinical and Experimental Hepatology 2: 76, No. 2, Jan 2016 [abstract] - PolandGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations